| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $280.0M | +35.5% |
| Cost of Revenue | $62.3M | +48.9% |
| Gross Profit | $217.8M | +32.1% |
| R&D Expense | $121.2M | +52.3% |
| SG&A Expense | $55.6M | -2.0% |
| Operating Income | -$89.8M | -31.4% |
| Pre-tax Income | -$84.7M | -25.3% |
| Income Tax | $5.4M | +258.9% |
| Net Income | -$90.2M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $45.6M | -33.2% |
| Short-term Investments | $397.6M | +12.7% |
| Accounts Receivable | $62.1M | +23.0% |
| Current Assets | $532.0M | +6.6% |
| Total Assets | $871.2M | +2.2% |
| Current Liabilities | $209.6M | +19.6% |
| Total Liabilities | $246.4M | +15.2% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $21.4M | -23.2% |
| Capital Expenditures | $4.3M | +2.4% |
| Investing Cash Flow | -$53.3M | +57.5% |
| Financing Cash Flow | $11.0M | +663.6% |
| Free Cash Flow | $17.1M | -27.8% |
| -40.5% |
| EPS (Basic) | -$0.91 | -33.8% |
| EPS (Diluted) | -$0.91 | -33.8% |
| Stockholders' Equity |
| $624.8M |
| -2.2% |